4//SEC Filing
DENBY WILLIAM C 4
Accession 0001593968-19-001242
CIK 0000887247other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 6:13 PM ET
Size
5.3 KB
Accession
0001593968-19-001242
Insider Transaction Report
Form 4
DENBY WILLIAM C
Director
Transactions
- Purchase
Common Stock
2019-05-24$1.60/sh+6,250$9,997→ 108,750 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple open market transactions at prices ranging from $1.595 to $1.60, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001279193
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 6:13 PM ET
- Size
- 5.3 KB